Clinical Trial Update: Lumigan Versus Cosopt [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Lumigan (bimatoprost) with Cosopt (dorzolamide-timolol) for open-angle glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Cosopt (dorzolamide/timolol)
• Lumigan (bimatoprost)

Snippet

Sponsor: Pharmaceutical Research Network | Conditions: Open-Angle Glaucoma | Phase 4 | Status: COMPLETED